There is an error in the [Table 2](#pone.0219612.t001){ref-type="table"} footnotes: "Rate^\$^ per 1000 person-year" should appear as "Rate^\$^ per 10000 person-year."

10.1371/journal.pone.0219612.t001

###### Incidence of obstructive sleep apnea and Cox method estimated hazard ratio of obstructive sleep apnea for asthma cohort compared with non-asthma cohort by demographic characteristics and comorbidity.

![](pone.0219612.t001){#pone.0219612.t001g}

  Variables                                                   Asthma                                                                                                       
  ----------------------------------------------------------- -------- --------- ------ ----- -------- ------ ------------------------------------------------------------ ------------------------------------------------------------
  Total                                                       521      1076209   4.84   328   269876   12.1   2.51 (2.19, 2.89)[\*\*\*](#t001fn006){ref-type="table-fn"}   1.87 (1.61, 2.17)[\*\*\*](#t001fn006){ref-type="table-fn"}
  **Sex**                                                                                                                                                                  
   Female                                                     229      596672    3.84   111   150340   7.38   1.93 (1.54, 2.42)[\*\*\*](#t001fn006){ref-type="table-fn"}   1.50 (1.17, 1.92)[\*\*](#t001fn005){ref-type="table-fn"}
   Male                                                       292      479537    6.09   217   119537   18.2   2.98 (2.50, 3.56)[\*\*\*](#t001fn006){ref-type="table-fn"}   2.14 (1.77, 2.59)[\*\*\*](#t001fn006){ref-type="table-fn"}
  **Age, years**                                                                                                                                                           
   20--34                                                     72       212911    3.38   45    54752    8.22   2.43 (1.67, 3.52)[\*\*\*](#t001fn006){ref-type="table-fn"}   1.63 (1.07, 2.49)[\*](#t001fn004){ref-type="table-fn"}
   35--49                                                     136      271160    5.02   103   68497    15.0   3.00 (2.32, 3.88)[\*\*\*](#t001fn006){ref-type="table-fn"}   1.91 (1.44, 2.54)[\*\*\*](#t001fn006){ref-type="table-fn"}
   50--64                                                     174      297741    5.84   120   74626    16.1   2.76 (2.18, 3.48)[\*\*\*](#t001fn006){ref-type="table-fn"}   2.00 (1.55, 2.58)[\*\*\*](#t001fn006){ref-type="table-fn"}
   ≥ 65                                                       139      294397    4.72   60    72001    8.33   1.77 (1.31, 2.39)[\*\*\*](#t001fn006){ref-type="table-fn"}   1.42 (1.03, 1.97)[\*](#t001fn004){ref-type="table-fn"}
  **Comorbidity**[^**‡**^](#t001fn003){ref-type="table-fn"}                                                                                                                
   No                                                         209      604795    3.46   50    75489    6.62   1.90 (1.40, 2.59)[\*\*\*](#t001fn006){ref-type="table-fn"}   1.90 (1.40, 2.59)[\*\*\*](#t001fn006){ref-type="table-fn"}
   Yes                                                        312      471414    6.62   278   194387   14.3   2.16 (1.84, 2.54)[\*\*\*](#t001fn006){ref-type="table-fn"}   2.05 (1.74, 2.41)[\*\*\*](#t001fn006){ref-type="table-fn"}

Rate^\$^ per 10000 person-year; Crude HR\#, relative hazard ratio;

† Model was adjusted for age, sex, and comorbidities of hypertension, diabetes, hyperlipidemia, COPD, CAD, stroke, rhinitis, chronic sinusitis, GERD and obesity;

‡ Patients with any comorbidity of hypertension, diabetes, hyperlipidemia, COPD, CAD, stroke, rhinitis, chronic sinusitis, GERD, and obesity was defined as the comorbidity group;

\*p\<0.05,

\*\*p\<0.01,

\*\*\*p\<0.001

There is an error in the [Table 5](#pone.0219612.t002){ref-type="table"} footnotes: "Rate^\$^ per 1000 person-year" should appear as "Rate^\$^ per 10000 person-year."

10.1371/journal.pone.0219612.t002

###### Cox proportional hazards regression analysis measured hazard ratio of obstructive sleep apnea among asthma patients by different treatments.
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  Variables              N       Event   PY       Rate^\$^   Crude HR^\#^ (95% CI)                                      Adjusted HR[^†^](#t002fn002){ref-type="table-fn"} (95% CI)
  ---------------------- ------- ------- -------- ---------- ---------------------------------------------------------- ------------------------------------------------------------
  Treatments of asthma                                                                                                  
  Non-steroid            13792   89      84271    10.6       1 (Reference)                                              1 (Reference)
  Inhaled steroid        11214   128     83602    15.3       1.46 (1.11, 1.92)[\*\*](#t002fn004){ref-type="table-fn"}   1.33 (1.01, 1.76)[\*](#t002fn003){ref-type="table-fn"}
  Systemic steroid       13834   111     102003   10.9       1.04 (0.79, 1.37)                                          1.01 (0.76, 1.34)

Rate^\$^ per 10000 person-year; Crude HR^\#^, relative hazard ratio;

† Model was adjusted for age, sex, and comorbidities of hypertension, diabetes, hyperlipidemia, COPD, CAD, stroke, rhinitis, chronic sinusitis, GERD and obesity;

\*p\<0.05,

\*\*p\<0.01
